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ORIGINAL ARTICLE 
ULTRASONOGRAPHIC OPTIC NERVE SHEATH DIAMETER 
MEASUREMENT FOR RAISED INTRACRANIAL PRESSURE IN A 
TERTIARY CARE CENTRE OF A DEVELOPING COUNTRY 
Naveed ur Rehman Siddiqui, Anwarul Haque, Qalab Abbas, Humaira Jurair, Basit 
Salam*, Raza Sayani* 
Department of Paediatric and Child Health, *Department of Radiology, Aga Khan University Hospital, Karachi-Pakistan 
Background: Intracranial hypertension is not an uncommon life-threatening syndrome, caused by 
a variety of non-neurological and neurological illnesses, and quick diagnosis, timely treatment of 
Raised Intracranial Pressure (ICP) is associated with improved outcome. Our aim of study was to 
determine ultrasonographic measurement of Optic nerve sheath diameter (ONSD) for raised ICP. 
Methods: Prospective case series done in Emergency and Paediatric critical care unit of Aga Khan 
University Hospital. ONSD measurement in millimetres was done by placing linear probe of 
ultrasound on eye ball. Results: Forty-eight patients were included in study with mean age of 
7.5±5.0 years with 21/48 (43.8%) between 1–8 years and 19/48 (39.6%) >8 years with 32/48 
(66.7%) were male. Non-traumatic coma was most common diagnosis 41/48 (85.4%) with 
infectious cause being most common while Traumatic brain injury constitutes 7/48 (14.6%). Ct 
scan brain was done in 39/48 (81.3%) while MRI brain in rest of patients. Raised ICP was found 
in 83.33% (40/48) patients with Ultrasonographic ONSD measurement as compared to CT 
scan/MRI 14/48 (29.2%). 85% of patients, showed ultrasonographic ONSD measurement 
suggestive of Raised ICP with GCS ≤12. Mean ONSD with signs of raised ICP in infants 4.64 
(±0.48), in 1–10 years 6.44 (±0.65), and in adolescent >10 years 6.28 (±0.62) ONSD respectively 
with ROC Curve showing Area Under Curve (AUC) 0.814 ( 95% CI, 0.692-0.936). Conclusion: 
We identified threshold of Ultrasonographic ONSD measurement in infants >4.0 mm, in children 
1–10 yrs >4.71 mm, in adolescent >10 yrs >5.43 mm for raised ICP with sensitivity and 
specificity of 100% and 60–66.7% respectively. 85% of patients showed raised ICP with 
Ultrasonographic ONSD measurement with GCS ≤12. 
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INTRODUCTION 
Intracranial hypertension is not an uncommon life 
threatening syndrome, which is caused by a variety of 
non-neurological and neurological illnesses, and 
quick diagnosis and timely treatment of Raised 
Intracranial Pressure (ICP) is associated with 
improved outcome.1 Although the invasive devices 
(Intraparenchymal, Intraventricular, subdural, 
epidural) for raised ICP monitoring remain the gold 
standard,2,3 but it is invasive and not always possible 
due to lack of availability of neurosurgeon in all 
hospital settings or contraindications such as 
thrombocytopenia or coagulopathy,4 and also it is 
responsible for multiple complications such as 
intracranial haemorrhages5 in 1.1–5.8% of cases,4 
mal functioning5 in 6.3–40% of cases,4 or various 
infections6 in 0–15% of cases4. However, Magnetic 
Resonance Imaging (MRI) and Computed 
tomography (CT) scan brain may be used to assess 
the increased ICP but they are costly, needs lengthy 
time to be done, have restricted availability, and more 
over necessitate dangerous patient transport in 
scenarios when patient is critically ill to be 
transported, also poor performance had been reported 
for CT scan brain for the identification of increased 
ICP.7,8 Even with normal CT scan the diagnosis of 
raised ICP ranges from 0–88%.9 Ultrasonographic 
Optic Nerve Sheath Diameter (ONSD) measurement 
is now becoming a simple bedside tool broadly used 
because of its low cost, and readily availability.10 In 
the critical care environment, ultrasonographic optic 
nerve sheath diameter measurement has ignited 
significant recent interest, due to its non- 
invasiveness, repeatable and quickly performed at 
bed side which makes it a valuable bedside 
diagnostic tool. Therefore, we aim to determine if 
ultrasonographic optic nerve sheath diameter 
measurement accurately predict raised ICP. The 
objective of this study was to determine whether the 
ultrasonographic Optic Nerve Sheath Diameter 
measurement can predict the raised ICP. 
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MATERIAL AND METHODS 
This case series was completed over six-month 
period from 1st September 2014 to 28 February 2015 
after the approval from Ethical review committee of 
Aga Khan University Hospital. Setting included 
Emergency room (ER) and paediatric intensive care 
unit (PICU) of Aga Khan University Hospital, 
Karachi. Ethical review committee of Aga Khan 
University Hospital approved the study (2747-Ped-
ERC-13). All data was recorded on password 
protection and confidentiality was maintained by 
using Code Numbers.  
Inclusion Criteria: 
All children from age 1 month -16 years with the 
following inclusion criteria10 was included in the 
study 
 Traumatic brain injury defined as a moderate 
with GCS 9-13 
 Traumatic brain Injury defined as a sever with 
GCS <9 
 Active malignancy history with new onset 
neurological symptoms. 
 Raised ICP clinical signs e.g. Anisocoric pupils, 
motor posturing, Cushing triad. 
 From ER to admission with Progressive 
neurological deterioration   
Exclusion Criteria: 
Patients with orbital trauma with orbital fractures, 
orbital tumor, and intraocular space occupying 
lesions were excluded from the study.  
The method for measurement of 
ultrasonographic ONSD was described in 
literature.1,11 We used a probe of 7.5 MHz linear 
array of ultrasound machine of Mindray. The depth 
was set to 5–6 cm. The probe was covered with 
gloves easily available with gel placed in it to prevent 
gel contact with the eyes which in turn prevent any 
reaction or possibility of infection with in the eye. 
The probe was then positioned over the closed eye, 
over the upper eyelid of the supine patient with head 
end elevated at 30 degrees in axial plane as shown in 
figure-1.12  
Two hyperechoec lines behind the globe was 
identified as optic nerve sheath. Almost, 3 mm 
behind the papilla, which suggested the best 
dispensability, maximum U/S contrast and high 
reproducibility was the point of measurement of outer 
limit of hyperechoec line using electronic callipers as 
shown in figure-2.12,13 We considered the upper limit 
for ONSD of 4 mm in age <1 yrs, 4.5 mm between 
1–10 years and >5 mm in age >10 years and were 
considered as a sign of raised ICP as consistent with 
recent literature.14–18 Measurements was taken in both 
eyes in the Emergency Room (ER) or Paediatric 
Intensive Care Unit(PICU) by an experienced trained 
physician or Intensive care fellow having experience 
of measurement of ONSD previously. Our Hospital 
ER and PICU have its own U/S machine available. 
Basic demographic data including age gender and 
weight with primary and associated diagnosis was 
collected after taking informed consent. Clinical 
indication for ONSD and CT scan findings were also 
collected as in proforma for patients in ER or PICU 
who met the inclusion criteria. The ultrasonographic 
optic nerve sheath diameter measurement was 
documented on structured proforma, and operator 
took 3 readings on each side and the sum will be 
calculated to get the mean and transferred to SPSS 20 
for the analysis.  
                  It includes measurement of mean ± 
standard deviation for continuous variables and 
frequencies of all categorical variables. ONSD of 4 
mm in age <1year, 4.5 mm between 1–10 yrs and >5 
mm in age >10 years was considered as a sign of 
raised ICP as in previous studies.14–18 Sensitivity, 
specificity, Positive predicted Value, and Negative 
predicted vale was calculated accordingly.19 ROC 
curve was made for ultrasonographic ONSD 
measurements in patients with clinical signs of raised 
ICP, in all age groups. 
RESULTS  
Over all, in the study, 48 patients were included, with 
mean age 7.5 years (±5) with 32 (66.7%) were male. 
Among these patients, 21 (43.8%) were between 1–
10 years and 19 (39.6%) were >10 years of age. Most 
of the patients presented with non-traumatic coma 
with primary neurological disorder mainly 
meningeoencephalitis 27 (56.25%) followed by 
stroke 7 (14.5%) as shown in table-1. Patients with 
GCS ≤12 constituted 87.5% (40/48), 85% of them 
showed ONSD measurement suggestive of Raised 
ICP. In majority of patients CT Scan brain 39 
(81.2%) was done, and MRI brain in 9 (18.8%). The 
most common indication for imaging among these 
patients includes Clinical signs of raised ICP with 
progressive neurological deterioration 26 (54.2%) 
followed by progressive neurological deterioration 
alone as shown in table-1.  
CT scans Brain/ MRI Brain of 14 (29.2%) 
patients were suggestive of raised ICP as compared 
to ultrasonographic ONSD measurement 40 
(83.33%). Also 85% of patients with GCS ≤12 
showed ultrasonographic ONSD measurement 
suggestive of Raised ICP. The CT scan brain and 
MRI brain findings suggestive of raised ICP were 
shown in figure-3. The mean values of ultrasound 
guided ONSD measurement for 3 age groups were 
shown in table-2. 
We identified threshold of Ultrasonographic 
ONSD measurement in infants >4.0 mm, in children 
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1–10 yrs >4.71 mm, in adolescent >10 yrs >5.43 mm 
for raised ICP with sensitivity and specificity of 
100% and 60–66.7% respectively, with positive 
predictive value of 100% and negative predictive 
value 35%. The ROC curve at various threshold of 
ultrasonographic ONSD measurement for clinical 
signs of raised ICP with Area under Curve (AUC) 
0.814 (95% CI, 0.692–0.936) is shown in figure-4.  
Figure-5.1, 5.2, and 5.3 showed the ROC 
curves at various age groups. The thresholds of 
Ultrasonographic ONSD measurement for the 
identification of raised ICP with respect to various 
age groups are shown in table-3. 
 
 
Figure-1: The probe was then positioned over the 




Figure-2: The technique of ocular ultrasound and 
the image with the cursors set at 3 mm behind the 
globe to measure the optic nerve sheath diameter12 
 
 
Figure-3: CT Scan/MRI brain finding suggestive 
of raised intracranial pressure. 
 
 
Figure-4: ROC curve at various thresholds ONSD 
measurement at all ages 
 
Figure-5.1: ROC curve at various thresholds 
ONSD measurement for patients >10 years of age 
 
Figure-5.2: ROC curve at various thresholds 
ONSD measurement for patient 1–10 years of age 
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Figure-5.3: ROC curve at various thresholds 
ONSD measurement for patients <1 year of age 
 
Table-1: Characteristics of patients 
Characteristics n=48(%) 
Age (yrs) mean +/-SD 7.5 (±5) 
    < 1 yrs 8 (16.7) 
   1-10 yrs 21 (43.8) 
    >10 yrs 19 (39.6) 
Gender  
    Male 32 (66.7) 
    Female 16 (33.3) 
Categories  
   Traumatic brain injury 7 (14.6) 
         Road traffic accidents 6 (12.5) 
         Blast injury 1 (2.08) 
   Non-Traumatic Coma 41 (85.4) 
         Primary Neurological injury 37 (75.5) 
               Meningeoencephalitis 27 (56.25) 
               Stroke 7 (14.5) 
               Status Epilepticus 2 (1.16) 
               Space occupying lesion 1 (2.08) 
        Secondary neurological injury 4 (8.33) 
               Diabetic Ketoacidosis 2 (4.16) 
               Wilson Disease 1 (2.08) 
               Hemolytic uremic syndrome 1 (2.08) 
GCS  
        ≤12 42 (87.5) 
        >12 6 (12.5) 
Clinical Indication for imaging  
        Moderate TBI 4 (8.33) 
        Sever TBI       4 (8.33) 
        Clinical Signs of Raised ICP 2 (4.16) 
        Clinical Signs + progressive neurological 
deterioration 
24 (50) 
        Progressive neurological deterioration 14 (29.1) 
Imaging  
        CT Scan brain 39 (81.2) 
        MRI brain 9 (18.8) 
Clinical signs suggestive of raised ICP 26 (54.2) 
CT Scan/MRI brain suggestive of raised ICP 14 (29.2) 
US Guided ONSD suggestive of raised ICP 40 (83.33) 
GCS with US Guided ONSD suggestive of 
raised ICP 
 
       ≤ 12                    36/42 (85.7) 
 
Table-2: US guided ONSD measurements 
Age ONSD mm Mean (±SD) ONSD mm Mean (±SD) 
Patients with signs of 
raised ICP 
3 (37.5%) 
Patients with no signs of 
raised ICP 
5 (62.5%) 
< 1 yrs 
n =8 
4.64 (±0.48) 4.32 (±0.71) 
Patients with signs of 
raised ICP 
10 (47.6%) 




n = 21 
6.44 (±0.65) 5.03 ±0.82) 
Patients with signs of 
raised ICP 
13 (68.4%) 




n = 19 
6.28 (±0.62) 5.46 (±0.91) 
 
Table-3: Sensitivity and specificity of US Guided 
ONSD measurement based on ROC curves 
Characteristics Sensitivity Specificity 
Age < 1 yrs   
    ONSD  =  3.96mm 100% 60% 
Age 1 - 10yrs   
     ONSD  = 4.71mm 100% 63.6% 
Age > 10 yrs   
     ONSD  = 5.43mm 100% 66.7% 
DISCUSSION 
The range of ONSD in normal paediatric population had 
been described in a number of previous studies. In US, 
67 children were recruited and they had used threshold 
of ultrasonographic ONSD in infants >4 mm and in 
children >1 year >4.5 mm to be considered as a sign of 
raised ICP.14 In UK, 102 normal children, 
Ultrasonographic ONSD ranged from 2.1 to 4.3 mm 
with ONSD >4 mm in infants and >4.5 mm in children 
>1 yr was considered and regarded as abnormal.18 
Another German study including 483 children 
concludes that Ultrasonographic ONSD >4.5 mm was 
definitely pathologic and requires further investigation.17 
In 7 African children with no signs of raised ICP, the 
range of Ultrasonographic ONSD was 2.8 to 4.4 mm 
with ONSD ≥4.5 mm was considered as a sign of raised 
ICP.15 In Irani 78 children, the control group showed the 
range of 2–4 mm and 2.8–4.35  in <4 years of age and 
>4 years of age respectively.20 In Bangladeshi cohort, 
136 healthy participants with age  ≥4 years and adults 
had given a range of 4.24–4.83 mm and considered 
>4.75 mm as abnormal.16 However, different studies 
showed the Ultrasonographic ONSD range of  2.9–4.3 
mm in 20 German adults,21 2.5–4.1 mm in 50 UK 
adults,22 and 2.2–4.9 mm in 26 Greek adults.23 Most of 
the previous studies in adults showed Ultrasonographic 
ONSD of greater than 5mm to 5.9 mm as a sign of 
raised ICP.12, 23–28 Considering the above mentioned data 
we considered Ultrasonographic ONSD in infants less 
than 1 yr. >4 mm, in children 1–10 yrs. >4.5 mm, and in 
adolescence greater than 1> yrs. >5 mm as a threshold 
for the identification of raised ICP.  
Our study showed the mean age of 7.5 years 
(±5 years) which was similar to the German cohort.17 
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However, the mean age was lower in African15 and 
Irani20 cohort, and slightly higher in US14 children. We 
also report the male preponderance in our study similar 
to US14 and Irani20 children. Our study showed 
Nontraumatic coma with meningeoencephalitis and 
stroke being the most common diagnosis which do 
correlate with the African cohort.15 However, Irani20 and 
US14 cohort showed the preponderance of head trauma, 
brain tumor, and Ventriculoperitoneal shunt 
malfunction. 
We report the mean ONSD with signs of 
raised ICP in infants 4.64 (±0.48), in 1–10 years 6.44 
(±0.65), and in adolescent >10 years 6.28 (±0.62) 
ONSD respectively which is greater than the cut off in 
infants greater than 4 mm, in children >1 yr. >4.5 mm, 
and in adults >5 mm as mentioned in previous 
studies.12,14-18,23-27 We report the Sensitivity of 
Ultrasonographic ONSD suggestive of raised ICP 65% 
which is much lower as compared to the other paediatric 
cohorts ranging from 83–100%,14,15 with specificity of 
100% greater than African15 cohort 86% and US14 
cohort 38%. However, when we plotted the ROC curves 
at various age groups as in figure 3, we found different 
threshold for the Ultrasonographic ONSD suggestive of 
raised ICP in different age groups as mentioned in table 
3, with sensitivity reaching 100% and specificity 
declining to 60–66.7%. Also the threshold for children 
age >1 yrs as shown in table 3, was lower as compared 
to the African15 cohort with mean Ultrasonographic 
ONSD 5.4 mm (range 4.3–6.2 mm) with raised ICP, 
Irani20 cohort with mean ONSD, age <4 years and > 4 
years, 5.55 mm (±0.68) and 5.68 mm (±0.71), 
respectively with raised ICP, and in German cohort17 
with mean ONSD of 5.6 mm (±0.9) with raised ICP. 
Therefore, we recommend the threshold of 
Ultrasonographic ONSD > 4 mm in infants, >4.71 in 
children age 1–10 yrs, and > 5.43 mm in adolescent age 
>10 yrs for the identification of raised ICP. 
In almost all patients, we had measured 
Ultrasonographic ONSD measurement with head end 
elevated at 30 degrees which is one of the 
neuroprotective measures in these critically ill 
neurological patients. Whether, there will be any 
differences in ONSD measurement with respect to the 
head end at 0ᵒ, 30ᵒ, 60ᵒ in the same patients at the same 
point in time, opens another area of research to identify 
the optimum threshold for raised ICP among children 
with different age groups. 
However, this non-invasive method can safely 
and rapidly provide information of ICP at bedside and 
can be frequently repeated. It also allows the observer to 
quickly assess the ICP variation, which is very 
important in these clinical scenarios, in the evaluation 
and follow-up of these patients, where invasive 
monitoring devices are not available or contraindicated. 
Thus, Ultrasonographic ONSD measurement in 
combination with raised ICP clinical signs can be used 
to identify raised ICP in such scenarios. 
Also, invasive monitoring is considered as 
gold standard and standard reference to compare the 
other modalities, but differences in the type of invasive 
ICP monitoring devices, site of insertion 
(Intraparenchymal, Intraventricular, subdural, epidural), 
location of tip at different places inside the skull with 
respect to different site of insertion also makes it 
difficult to accurately monitor the exact ICP especially 
in case with the localised disease process. 
The reader of this study needs to know that 
there were several limitations while interpreting this 
study. In our cohort we used clinical signs of raised ICP 
as a surrogate marker of raised ICP, as direct invasive 
monitoring which is considered as gold standard is not 
frequently performed and recruiting the patients with 
subject to invasive ICP monitoring was not feasible. 
Also most of our patients had undergone CT scan brain 
with few MRI brain within 2 hrs of Ultrasonographic 
ONSD measurement, but CT scan has been considered 
as a poor surrogate marker to identify raised ICP.7,8 
Even with normal CT scan brain, the chances of raised 
ICP ranges from 0–88%.9 Also in our cohort with 
radiological imaging, only 29% (14/48) of patients  had 
shown signs of raised ICP, although these number also 
included 9 MRI brain which has far better sensitivity 
and specificity for diagnosing raised ICP.  
With different operator for Ultrasonographic 
ONSD measurement, there can be operator bias as 
ultrasonography is highly operator dependant. Despite 
of extensive efforts during the training of the operators 
(Intensive care physicians and fellows) to standardise 
the image capturing, with optic nerve in the centre of the 
screen and measurement to be taken 3 mm behind the 
papilla. 
In our cohort, the sample size was small 
especially in infants. Therefore, larger prospective study 
would be needed among children with different age 
groups to establish the accurateness of Ultrasonographic 
ONSD measurement as an acceptable, non-invasive, 
safe, and easily repeatable screening and diagnostic tool 
for the diagnosis of raised ICP. 
CONCLUSION 
We report the threshold of Ultrasonographic ONSD 
measurement in infants >4.0 mm, in children 1–10 yrs > 
4.71 mm, in adolescent >10 yrs >5.43 mm for 
identifying the raised ICP with sensitivity and 
specificity of 100% and 60–66.7% respectively. We 
also Report 85% of patients with GCS ≤12 showing 
raised ICP with ultrasonographic ONSD measurement. 
Ultrasonographic ONSD measurement in combination 
with GCS can be considered a better screening tool for 
identification of increased ICP especially in a resource 
limited developing country. 
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